Trupanion (NASDAQ:TRUP) CFO Fawwad Qureshi Sells 6,177 Shares of Stock

Posted by Stanley Muller on May 28th, 2026

Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CFO Fawwad Qureshi sold 6,177 shares of the business’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total value of $137,005.86. Following the transaction, the chief financial officer owned 2,081 shares of the company’s stock, valued at $46,156.58. This trade represents a 74.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Fawwad Qureshi also recently made the following trade(s):

On Friday, February 27th, Fawwad Qureshi sold 2,837 shares of Trupanion stock. The stock was sold at an average price of $26.46, for a total value of $75,067.02.

Trupanion Trading Down 0.8%

Shares of TRUP stock opened at $21.69 on Thursday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.73 and a current ratio of 1.73. Trupanion, Inc. has a 1 year low of $21.16 and a 1 year high of $57.88. The stock has a fifty day moving average of $25.08 and a two-hundred day moving average of $30.52. The firm has a market capitalization of $946.12 million, a PE ratio of 36.76 and a beta of 1.49.

Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The company had revenue of $384.05 million during the quarter, compared to analyst estimates of $379.77 million. During the same quarter in the previous year, the firm posted ($0.03) EPS. The firm’s quarterly revenue was up 12.3% on a year-over-year basis. As a group, research analysts expect that Trupanion, Inc. will post 0.53 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have recently weighed in on TRUP. Piper Sandler cut their price objective on Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a report on Friday, February 13th. Weiss Ratings lowered Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 4th. Cantor Fitzgerald cut their price objective on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a report on Friday, February 13th. Finally, Stifel Nicolaus cut their price objective on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a report on Tuesday, March 31st. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Trupanion has a consensus rating of “Hold” and a consensus price target of $42.25.

View Our Latest Stock Analysis on TRUP

Institutional Investors Weigh In On Trupanion

Several hedge funds have recently modified their holdings of the stock. Federated Hermes Inc. acquired a new position in Trupanion during the third quarter valued at $33,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Trupanion during the third quarter valued at $39,000. Parallel Advisors LLC raised its position in Trupanion by 1,831.9% during the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after buying an additional 1,722 shares during the period. Kemnay Advisory Services Inc. acquired a new position in Trupanion during the fourth quarter valued at $64,000. Finally, Kelleher Financial Advisors acquired a new position in Trupanion during the third quarter valued at $74,000.

About Trupanion

(Get Free Report)

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.